Organization, Basis of Presentation and Liquidity - Schedule of Ownership of Outstanding Shares of Its Subsidiaries (Details)	12 Months Ended
	Dec. 31, 2020
ReCyte Therapeutics, Inc. [Member]
Field of Business	Early stage pre-clinical research and development involved in stem cell-derived endothelial and cardiovascular related progenitor cells for the treatment of vascular disorders, and ischemic conditions
Agex Ownership	94.80%
Country	USA
LifeMap Sciences, Inc. [Member]
Field of Business	Biomedical, gene and disease databases and tools	[1]
Agex Ownership	80.70%	[1]
Country	USA	[1]

[1] On March 15, 2021, LifeMap Sciences was acquired by a third party in a cash-out merger. LifeMap Sciences includes LifeMap Sciences, Inc. and its wholly-owned subsidiary LifeMap Sciences, Ltd. an Israeli company which has discontinued operations, and proceedings have been commenced to dissolve the Israeli subsidiary. (See Note 9)